1h Free Analyst Time
The publisher has been monitoring the gemcitabine hydrochloride market and it is poised to grow by $325.19 mn during 2022-2026 progressing at a CAGR of 7.09% during the forecast period. The report on the gemcitabine hydrochloride market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing cancer population, growing preference for chemotherapy drugs in developing countries, and approval of new drugs fuels the market growth.
The gemcitabine hydrochloride market analysis includes the type segment and geographic landscape.
The gemcitabine hydrochloride market is segmented as below:
By Type
- Generic
- Branded
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the robust R&D activities fueling the pipeline as one of the prime reasons driving the gemcitabine hydrochloride market growth during the next few years. Also, novel treatment options coupled with new applications and increasing inorganic growth strategies likely to fuel the market growth will lead to sizable demand in the market.
The report on gemcitabine hydrochloride market covers the following areas:
- Gemcitabine hydrochloride market sizing
- Gemcitabine hydrochloride market forecast
- Gemcitabine hydrochloride market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gemcitabine hydrochloride market vendors that include Apotex Inc., Biocon Ltd., Cipla Ltd., Dr. Reddys Laboratories Ltd., Eli Lilly and Co., Emcure Pharmaceuticals Ltd., Fresenius Kabi AG, Ingenus Pharmaceuticals LLC, Intas Pharmaceuticals Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Lianyungang Jinkang Pharmaceutical Technology Co. Ltd., Merck KGaA, Nichi-Iko Pharmaceutical Co. Ltd., Pfizer Inc., Shilpa Medicare Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and ZHEJIANG HISUN PHARMACEUTICAL Co. Ltd. Also, the gemcitabine hydrochloride market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2. Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3. Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4. Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5. Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Generic - Market size and forecast 2021-2026
Exhibit 28: Chart on Generic - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Generic - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Generic - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Generic - Year-over-year growth 2021-2026 (%)
5.4 Branded - Market size and forecast 2021-2026
Exhibit 32: Chart on Branded - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Branded - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Branded - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Branded - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Type
Exhibit 36: Market opportunity by Type ($ million)
6. Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7. Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 Canada - Market size and forecast 2021-2026
Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)
8. Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9. Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10. Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Apotex Inc.
Exhibit 85: Apotex Inc. - Overview
Exhibit 86: Apotex Inc. - Product / Service
Exhibit 87: Apotex Inc. - Key offerings
10.4 Biocon Ltd.
Exhibit 88: Biocon Ltd. - Overview
Exhibit 89: Biocon Ltd. - Business segments
Exhibit 90: Biocon Ltd. - Key offerings
Exhibit 91: Biocon Ltd. - Segment focus
10.5 Eli Lilly and Co.
Exhibit 92: Eli Lilly and Co. - Overview
Exhibit 93: Eli Lilly and Co. - Product / Service
Exhibit 94: Eli Lilly and Co. - Key offerings
10.6 Fresenius Kabi AG
Exhibit 95: Fresenius Kabi AG - Overview
Exhibit 96: Fresenius Kabi AG - Business segments
Exhibit 97: Fresenius Kabi AG - Key news
Exhibit 98: Fresenius Kabi AG - Key offerings
Exhibit 99: Fresenius Kabi AG - Segment focus
10.7 Intas Pharmaceuticals Ltd.
Exhibit 100: Intas Pharmaceuticals Ltd. - Overview
Exhibit 101: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 102: Intas Pharmaceuticals Ltd. - Key offerings
10.8 Jiangsu Hansoh Pharmaceutical Group Co. Ltd.
Exhibit 103: Jiangsu Hansoh Pharmaceutical Group Co. Ltd. - Overview
Exhibit 104: Jiangsu Hansoh Pharmaceutical Group Co. Ltd. - Product / Service
Exhibit 105: Jiangsu Hansoh Pharmaceutical Group Co. Ltd. - Key offerings
10.9 Nichi-Iko Pharmaceutical Co. Ltd.
Exhibit 106: Nichi-Iko Pharmaceutical Co. Ltd. - Overview
Exhibit 107: Nichi-Iko Pharmaceutical Co. Ltd. - Product / Service
Exhibit 108: Nichi-Iko Pharmaceutical Co. Ltd. - Key offerings
10.10 Pfizer Inc.
Exhibit 109: Pfizer Inc. - Overview
Exhibit 110: Pfizer Inc. - Product / Service
Exhibit 111: Pfizer Inc. - Key news
Exhibit 112: Pfizer Inc. - Key offerings
10.11 Teva Pharmaceutical Industries Ltd.
Exhibit 113: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 114: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 115: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 116: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 117: Teva Pharmaceutical Industries Ltd. - Segment focus
10.12 Viatris Inc.
Exhibit 118: Viatris Inc. - Overview
Exhibit 119: Viatris Inc. - Business segments
Exhibit 120: Viatris Inc. - Key offerings
Exhibit 121: Viatris Inc. - Segment focus
11. Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 122: Inclusions checklist
Exhibit 123: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 124: Currency conversion rates for US$
11.4 Research methodology
Exhibit 125: Research methodology
Exhibit 126: Validation techniques employed for market sizing
Exhibit 127: Information sources
11.5 List of abbreviations
Exhibit 128: List of abbreviations
List of ExhibitsExhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Type - Market share 2021-2026 (%)
Exhibits 25: Data Table on Type - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Type
Exhibits 27: Data Table on Comparison by Type
Exhibits 28: Chart on Generic - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Generic - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Generic - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Generic - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Branded - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Branded - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Branded - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Branded - Year-over-year growth 2021-2026 (%)
Exhibits 36: Market opportunity by Type ($ million)
Exhibits 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 40: Chart on Geographic comparison
Exhibits 41: Data Table on Geographic comparison
Exhibits 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 78: Market opportunity By Geographical Landscape ($ million)
Exhibits 79: Impact of drivers and challenges in 2021 and 2026
Exhibits 80: Overview on Criticality of inputs and Factors of differentiation
Exhibits 81: Overview on factors of disruption
Exhibits 82: Impact of key risks on business
Exhibits 83: Vendors covered
Exhibits 84: Matrix on vendor position and classification
Exhibits 85: Apotex Inc. - Overview
Exhibits 86: Apotex Inc. - Product / Service
Exhibits 87: Apotex Inc. - Key offerings
Exhibits 88: Biocon Ltd. - Overview
Exhibits 89: Biocon Ltd. - Business segments
Exhibits 90: Biocon Ltd. - Key offerings
Exhibits 91: Biocon Ltd. - Segment focus
Exhibits 92: Eli Lilly and Co. - Overview
Exhibits 93: Eli Lilly and Co. - Product / Service
Exhibits 94: Eli Lilly and Co. - Key offerings
Exhibits 95: Fresenius Kabi AG - Overview
Exhibits 96: Fresenius Kabi AG - Business segments
Exhibits 97: Fresenius Kabi AG - Key news
Exhibits 98: Fresenius Kabi AG - Key offerings
Exhibits 99: Fresenius Kabi AG - Segment focus
Exhibits 100: Intas Pharmaceuticals Ltd. - Overview
Exhibits 101: Intas Pharmaceuticals Ltd. - Product / Service
Exhibits 102: Intas Pharmaceuticals Ltd. - Key offerings
Exhibits 103: Jiangsu Hansoh Pharmaceutical Group Co. Ltd. - Overview
Exhibits 104: Jiangsu Hansoh Pharmaceutical Group Co. Ltd. - Product / Service
Exhibits 105: Jiangsu Hansoh Pharmaceutical Group Co. Ltd. - Key offerings
Exhibits 106: Nichi-Iko Pharmaceutical Co. Ltd. - Overview
Exhibits 107: Nichi-Iko Pharmaceutical Co. Ltd. - Product / Service
Exhibits 108: Nichi-Iko Pharmaceutical Co. Ltd. - Key offerings
Exhibits 109: Pfizer Inc. - Overview
Exhibits 110: Pfizer Inc. - Product / Service
Exhibits 111: Pfizer Inc. - Key news
Exhibits 112: Pfizer Inc. - Key offerings
Exhibits 113: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 114: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 115: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 116: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 117: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 118: Viatris Inc. - Overview
Exhibits 119: Viatris Inc. - Business segments
Exhibits 120: Viatris Inc. - Key offerings
Exhibits 121: Viatris Inc. - Segment focus
Exhibits 122: Inclusions checklist
Exhibits 123: Exclusions checklist
Exhibits 124: Currency conversion rates for US$
Exhibits 125: Research methodology
Exhibits 126: Validation techniques employed for market sizing
Exhibits 127: Information sources
Exhibits 128: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global gemcitabine hydrochloride market: Apotex Inc., Biocon Ltd., Cipla Ltd., Dr. Reddys Laboratories Ltd., Eli Lilly and Co., Emcure Pharmaceuticals Ltd., Fresenius Kabi AG, Ingenus Pharmaceuticals LLC, Intas Pharmaceuticals Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Lianyungang Jinkang Pharmaceutical Technology Co. Ltd., Merck KGaA, Nichi-Iko Pharmaceutical Co. Ltd., Pfizer Inc., Shilpa Medicare Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and ZHEJIANG HISUN PHARMACEUTICAL Co. Ltd.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is robust R&D activities fueling the pipeline.`
According to the report, one of the major drivers for this market is the increasing cancer population drive the market growth.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Apotex Inc.
- Biocon Ltd.
- Cipla Ltd.
- Dr. Reddys Laboratories Ltd.
- Eli Lilly and Co.
- Emcure Pharmaceuticals Ltd.
- Fresenius Kabi AG
- Ingenus Pharmaceuticals LLC
- Intas Pharmaceuticals Ltd.
- Jiangsu Hansoh Pharmaceutical Group Co. Ltd.
- Lianyungang Jinkang Pharmaceutical Technology Co. Ltd.
- Merck KGaA
- Nichi-Iko Pharmaceutical Co. Ltd.
- Pfizer Inc.
- Shilpa Medicare Ltd.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- ZHEJIANG HISUN PHARMACEUTICAL Co. Ltd.
